The subject invention concerns novel compounds that are useful as
ultrashort acting hypnotic barbiturates. Specifically exemplified are
derivatives of barbituric and thiobarbituric acids. They are rapidly
metabolized by blood and tissue enzymes to form polar metabolites with no
hypnotic activity and which are rapidly eliminated.